Inapsine and Hypertension aggravated - a phase IV clinical study of FDA data

Summary:

Hypertension aggravated is reported as a side effect among people who take Inapsine (droperidol), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ambien, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Hypertension aggravated when taking Inapsine. It is created by eHealthMe based on reports of 259 people who have side effects when taking Inapsine from the FDA, and is updated regularly.

What is Inapsine?

Inapsine has active ingredients of droperidol. eHealthMe is studying from 260 Inapsine users. Check the latest studies of Inapsine.

What is Hypertension aggravated?

Hypertension aggravated (high blood pressure) is found to be associated with 2,738 drugs and 844 conditions by eHealthMe. Check the latest studies of Hypertension aggravated.

On Aug, 12, 2026

259 people reported to have side effects when taking Inapsine.
Among them, 32 people (12.36%) have Hypertension aggravated.

Could Inapsine cause Hypertension aggravated?

Among these 32 people:

How long have people been on Inapsine when they have Hypertension aggravated? *

What is the gender of people who have Hypertension aggravated when taking Inapsine? *

female: 93.75 %
male: 6.25 %

What is the age of people who have Hypertension aggravated when taking Inapsine? *

What are other drugs people take besides Inapsine? *

What are other side effects people have besides Hypertension aggravated? *

Stress And Anxiety: 19 people, 59.38%
Insomnia (sleeplessness): 18 people, 56.25%
Hypokalemia (low potassium): 17 people, 53.12%
Type 2 Diabetes: 17 people, 53.12%
Pleural Effusion (water on the lungs): 16 people, 50.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 16 people, 50.00%
Injury: 16 people, 50.00%
Fever: 16 people, 50.00%
Pain: 16 people, 50.00%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 16 people, 50.00%

What are the existing conditions these people have? *

Pain: 5 people, 15.62%
Breast Cancer Metastatic: 5 people, 15.62%
Type 1 Diabetes: 1 person, 3.12%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.12%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 3.12%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 3.12%
Pericardial Effusion (fluid around the heart): 1 person, 3.12%
Migraine (headache): 1 person, 3.12%
High Blood Cholesterol: 1 person, 3.12%
Heart Rate Increased: 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Inapsine and have Hypertension aggravated?

- Check whether Hypertension aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Inapsine:

Inapsine (260 reports)

Browse all side effects of Inapsine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertension aggravated:

Hypertension aggravated (2,738 drugs)

Browse all the conditions that are associated with Hypertension aggravated:

Hypertension aggravated (844 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on droperidol (the active ingredients of Inapsine) and Inapsine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.